Association of the MMP7 –181A>G promoter polymorphism with early onset of chronic obstructive pulmonary disease

1GOLD 2017. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2017 report. [Available from http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/.]GOLD 2017. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2017 reportAvailable fromhttp://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/Search in Google Scholar

2Echave-Sustaeta JM, Comeche Casanova L, Cosio BG, Soler-Cataluna JJ, Garcia-Lujan R, Ribera X. Comor-bidity in chronic obstructive pulmonary disease. Related to disease severity? Int J Chron Obstruct Pulmon Dis. 2014; 9: 1307-1314.Echave-SustaetaJMComeche CasanovaLCosioBGSoler-CatalunaJJGarcia-LujanRRiberaX.Comor-bidity in chronic obstructive pulmonary diseaseRelated to disease severity? Int J Chron Obstruct Pulmon Dis.201491307131410.2147/COPD.S71849Search in Google Scholar

3Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pul-monary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007; 176(6): 532-555.RabeKFHurdSAnzuetoABarnesPJBuistSACalverleyPGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pul-monary disease: GOLD executive summaryAm J Respir Crit Care Med.2007176653255510.1164/rccm.200703-456SOSearch in Google Scholar

4Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet. 2004; 364(9435): 709-721.HoggJC.Pathophysiology of airflow limitation in chronic obstructive pulmonary diseaseLancet.2004364943570972110.1016/S0140-6736(04)16900-6Search in Google Scholar

5Parks WC. Matrix metalloproteinases in lung repair. Eur Respir J Suppl. 2003; 44: 36s-8s.ParksWC.Matrix metalloproteinases in lung repairEur Respir J Suppl.20034436s8s10.1183/09031936.03.00001203Search in Google Scholar

6Gharib SA, Altemeier WA, Van Winkle LS, Plopper CG, Schlesinger SY, Buell CA, et al. Matrix metallo-proteinase-7 coordinates airway epithelial injury response and differentiation of ciliated cells. Am J Respir Cell Mol Biol. 2013; 48(3): 390-396.GharibSAAltemeierWAVan WinkleLSPlopperCGSchlesingerSYBuellCAMatrix metallo-proteinase-7 coordinates airway epithelial injury response and differentiation of ciliated cellsAm J Respir Cell Mol Biol.201348339039610.1165/rcmb.2012-0083OCSearch in Google Scholar

7McGuire JK, Li Q, Parks WC. Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium. Am J Pathol. 2003; 162(6): 1831-1843.McGuireJKLiQParksWC.Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epitheliumAm J Pathol.200316261831184310.1016/S0002-9440(10)64318-0Search in Google Scholar

8Vandenbroucke RE, Dejonckheere E, Libert C. A therapeutic role for matrix metalloproteinase inhibitors in lung diseases? Eur Respir J. 2011; 38(5): 1200-1214.VandenbrouckeREDejonckheereELibertC.A therapeutic role for matrix metalloproteinase inhibitors in lung diseases?Eur Respir J.20113851200121410.1183/09031936.00027411Search in Google Scholar

9McCawley LJ, Matrisian LM. Matrix metallo-proteinases: They’re not just for matrix anymore! Curr Opin Cell Biol. 2001; 13(5): 534-540.McCawleyLJMatrisianLM.Matrix metallo-proteinases: They’re not just for matrix anymore!Curr Opin Cell Biol.200113553454010.1016/S0955-0674(00)00248-9Search in Google Scholar

10Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ Res. 2003; 92(8): 827-839.VisseRNagaseH.Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistryCirc Res.200392882783910.1161/01.RES.0000070112.80711.3D12730128Search in Google Scholar

11Han JC, Li XD, Du J, Xu F, Wei YJ, Li HB, et al. Elevated matrix metalloproteinase-7 expression promotes metastasis in human lung carcinoma. World J Surg Oncol. 2015; 13(5): 1477-7819.HanJCLiXDDuJXuFWeiYJLiHBElevated matrix metalloproteinase-7 expression promotes metastasis in human lung carcinomaWorld J Surg Oncol.20151351477781910.1186/1477-7819-13-5432647125588786Search in Google Scholar

12Dunsmore SE, Saarialho-Kere UK, Roby JD, Wilson CL, Matrisian LM, Welgus HG, et al. Matrilysin expression and function in airway epithelium. J Clin Invest. 1998; 102(7): 1321-1331.DunsmoreSESaarialho-KereUKRobyJDWilsonCLMatrisianLMWelgusHGMatrilysin expression and function in airway epitheliumJ Clin Invest.199810271321133110.1172/JCI1516Search in Google Scholar

13Li Q, Park PW, Wilson CL, Parks WC. Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell. 2002; 111(5): 635-646.LiQParkPWWilsonCLParksWC.Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injuryCell.2002111563564610.1016/S0092-8674(02)01079-6Search in Google Scholar

14Manicone AM, Huizar I, McGuire JK. Matrilysin (matrix metalloproteinase-7) regulates anti-inflammatory and antifibrotic pulmonary dendritic cells that express CD103 (α^Eβ⁷-integrin). Am J Pathol. 2009; 175(6): 2319-2331.ManiconeAMHuizarIMcGuireJK.Matrilysin (matrix metalloproteinase-7) regulates anti-inflammatory and antifibrotic pulmonary dendritic cells that express CD103 (α^Eβ⁷-integrin)Am J Pathol.200917562319233110.2353/ajpath.2009.090101278961619893044Search in Google Scholar

15Jormsjo S, Whatling C, Walter DH, Zeiher AM, Hamsten A, Eriksson P. Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hyper-cholesterolemic patients. Arterioscler Thromb Vasc Biol. 2001; 21(11): 1834-1839.JormsjoSWhatlingCWalterDHZeiherAMHamstenAErikssonP.Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hyper-cholesterolemic patientsArterioscler Thromb Vasc Biol.200121111834183910.1161/hq1101.09822911701474Search in Google Scholar

16Beeghly-Fadiel A, Shu XO, Long J, Li C, Cai Q, Cai H, et al. Genetic polymorphisms in the MMP-7 gene and breast cancer survival. Int J Cancer. 2009; 124(1): 208-214.Beeghly-FadielAShuXOLongJLiCCaiQCaiHGenetic polymorphisms in the MMP-7 gene and breast cancer survivalInt J Cancer.2009124120821410.1002/ijc.23859259769818798254Search in Google Scholar

17Liu D, Guo H, Li Y, Xu X, Yang K, Bai Y. Association between polymorphisms in the promoter regions of matrix metalloproteinases (MMPs) and risk of cancer metastasis: A meta-analysis. PLoS One. 2012;7(2):14.LiuDGuoHLiYXuXYangKBaiY.Association between polymorphisms in the promoter regions of matrix metalloproteinases (MMPs) and risk of cancer metastasis: A meta-analysisPLoS One.2012721410.1371/journal.pone.0031251327937022348060Search in Google Scholar

18Scherf DB, Dally H, Muller P, Werle-Schneider G, Jager B, Edler L, et al. Single nucleotide polymorphisms in matrix metalloproteinase genes and lung cancer chemo-therapy response and prognosis. Eur Respir J. 2010; 35(2): 381-390.ScherfDBDallyHMullerPWerle-SchneiderGJagerBEdlerLSingle nucleotide polymorphisms in matrix metalloproteinase genes and lung cancer chemo-therapy response and prognosisEur Respir J.201035238139010.1183/09031936.0012560819643940Search in Google Scholar

19Ji X, Wang L, Wu B, Han R, Han L, Wang T, et al. Associations of MMP1, MMP2 and MMP3 genes polymorphism with coal workers’ pneumoconiosis in Chinese Han Population. Int J Environ Res Public Health. 2015; 12(11): 13901-13912.JiXWangLWuBHanRHanLWangTAssociations of MMP1, MMP2 and MMP3 genes polymorphism with coal workers’ pneumoconiosis in Chinese Han PopulationInt J Environ Res Public Health.20151211139011391210.3390/ijerph121113901466162226528997Search in Google Scholar

20Kastelijn EA, van Moorsel CH, Ruven HJ, Karthaus V, Kwakkel-van Erp JM, van de Graaf EA, et al. Genetic polymorphisms in MMP7 and reduced serum levels associate with the development of bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant. 2010; 29(6):680-686.KastelijnEAvan MoorselCHRuvenHJKarthausVKwakkel-van ErpJMvan de GraafEAGenetic polymorphisms in MMP7 and reduced serum levels associate with the development of bronchiolitis obliterans syndrome after lung transplantationJ Heart Lung Transplant.201029668068610.1016/j.healun.2010.01.00820347338Search in Google Scholar

21Richards TJ, Park C, Chen Y, Gibson KF, Peter Di Y, Pardo A, et al. Allele-specific transactivation of matrix metalloproteinase 7 by FOXA2 and correlation with plasma levels in idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2012; 302(8): L746-L754.RichardsTJParkCChenYGibsonKFPeter DiYPardoAAllele-specific transactivation of matrix metalloproteinase 7 by FOXA2 and correlation with plasma levels in idiopathic pulmonary fibrosisAm J Physiol Lung Cell Mol Physiol.20123028L746L75410.1152/ajplung.00319.2011333157922268124Search in Google Scholar

22Montano M, Sansores RH, Becerril C, Cisneros J, Gonzalez-Avila G, Sommer B, et al. FEV1 inversely correlates with metalloproteinases 1, 7, 9 and CRP in COPD by biomass smoke exposure. Respir Res. 2014; 15: 74. 1186/1465-9921-15-74.MontanoMSansoresRHBecerrilCCisnerosJGonzalez-AvilaGSommerBFEV1 inversely correlates with metalloproteinases 1, 7, 9 and CRP in COPD by biomass smoke exposureRespir Res.201415741186/1465-9921-15-74Open DOISearch in Google Scholar

23Mogulkoc U, Coskunpinar E, Aynaci E, Caglar E, Ortakoylu MG, Ozkan G, et al. Is MMP-7 gene polymor-phism a possible risk factor for chronic obstructive pul-monary disease in Turkish patients. Genet Test Mol Biomarkers. 2012; 16(6): 519-523.MogulkocUCoskunpinarEAynaciECaglarEOrtakoyluMGOzkanGIs MMP-7 gene polymor-phism a possible risk factor for chronic obstructive pul-monary disease in Turkish patientsGenet Test Mol Biomarkers.201216651952310.1089/gtmb.2011.027122417142Search in Google Scholar

24Preacher KJ. Calculation for the χ² test: An interactive calculation too for χ² tests of goodness of fit and independence [Computer software]. 2001. [Available from http://www.quantpsy.org/.]PreacherKJ.Calculation for the χ² testAn interactive calculation too for χ² tests of goodness of fit and independence [Computer software]2001Available fromhttp://www.quantpsy.org/Search in Google Scholar

25Demedts IK, Brusselle GG, Bracke KR, Vermaelen KY, Pauwels RA. Matrix metalloproteinases in asthma and COPD. Curr Opin Pharmacol. 2005; 5(3): 257-263.DemedtsIKBrusselleGGBrackeKRVermaelenKYPauwelsRA.Matrix metalloproteinases in asthma and COPDCurr Opin Pharmacol.20055325726310.1016/j.coph.2004.12.00515907912Search in Google Scholar

26Lu L, Gunja-Smith Z, Woessner JF, Ursell PC, Nissen T, Galardy RE, et al. Matrix metalloproteinases and collagen ultrastructure in moderate myocardial ischemia and reperfusion in vivo. Am J Physiol Heart Circ Physiol. 2000; 279(2): H601-H609.LuLGunja-SmithZWoessnerJFUrsellPCNissenTGalardyREMatrix metalloproteinases and collagen ultrastructure in moderate myocardial ischemia and reperfusion in vivoAm J Physiol Heart Circ Physiol.20002792H601H60910.1152/ajpheart.2000.279.2.H60110924059Search in Google Scholar

27Yoon HK, Cho HY, Kleeberger SR. Protective role of matrix metalloproteinase-9 in ozone-induced airway inflammation. Environ Health Perspect. 2007; 115(11): 1557-1563.YoonHKChoHYKleebergerSR.Protective role of matrix metalloproteinase-9 in ozone-induced airway inflammationEnviron Health Perspect.2007115111557156310.1289/ehp.10289207282518007984Search in Google Scholar

28Kofla-Dlubacz A, Matusiewicz M, Krzystek-Korpacka M, Iwanczak B. Correlation of MMP-3 and MMP-9 with Crohn’s disease activity in children. Dig Dis Sci. 2012; 57(3): 706-712.Kofla-DlubaczAMatusiewiczMKrzystek-KorpackaMIwanczakB.Correlation of MMP-3 and MMP-9 with Crohn’s disease activity in childrenDig Dis Sci.201257370671210.1007/s10620-011-1936-z328289521997756Search in Google Scholar

29Brajer B, Batura-Gabryel H, Nowicka A, Kuznar-Kaminska B, Szczepanik A. Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression. J Physiol Pharmacol. 2008; 59(Suppl 6): 145-152.BrajerBBatura-GabryelHNowickaAKuznar-KaminskaBSzczepanikA.Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progressionJ Physiol Pharmacol.200859Suppl 6145152Search in Google Scholar

30Ostridge K, Williams N, Kim V, Harden S, Bourne S, Coombs NA, et al. Distinct emphysema subtypes defined by quantitative CT analysis are associated with specific pulmonary matrix metalloproteinases. Respir Res. 2016; 17(1): 92. 1186/s12931-016-0402-z.OstridgeKWilliamsNKimVHardenSBourneSCoombsNADistinct emphysema subtypes defined by quantitative CT analysis are associated with specific pulmonary matrix metalloproteinasesRespir Res.2016171921186/s12931-016-0402-zOpen DOISearch in Google Scholar

31Manjari KS, Jyothy A, Kumar PS, Prabhakar B, Nallari P, Venkateshwari A. Association of matrix metalloproteinase-7 (-181A/G) promoter polymorphism in chronic pancreatitis. Indian J Med Res. 2014; 140(5): 609-615.ManjariKSJyothyAKumarPSPrabhakarBNallariPVenkateshwariA.Association of matrix metalloproteinase-7 (-181A/G) promoter polymorphism in chronic pancreatitisIndian J Med Res.20141405609615Search in Google Scholar

32Belaaouaj AA, Li A, Wun TC, Welgus HG, Shapiro SD. Matrix metalloproteinases cleave tissue factor pathway inhibitor. Effects on coagulation. J Biol Chem. 2000; 275(35): 27123-27128.BelaaouajAALiAWunTCWelgusHGShapiroSD.Matrix metalloproteinases cleave tissue factor pathway inhibitor Effects on coagulationJ Biol Chem.200027535271232712810.1074/jbc.M00421820010859319Search in Google Scholar